46 related articles for article (PubMed ID: 1303177)
21. Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome.
Wilson PJ; Suthers GK; Callen DF; Baker E; Nelson PV; Cooper A; Wraith JE; Sutherland GR; Morris CP; Hopwood JJ
Hum Genet; 1991 Mar; 86(5):505-8. PubMed ID: 1901826
[TBL] [Abstract][Full Text] [Related]
22. Deletion of the Hunter gene and both DXS466 and DXS304 in a patient with mucopolysaccharidosis type II.
Beck M; Steglich C; Zabel B; Dahl N; Schwinger E; Hopwood JJ; Gal A
Am J Med Genet; 1992 Sep; 44(1):100-3. PubMed ID: 1355630
[TBL] [Abstract][Full Text] [Related]
23. The iduronate sulfatase gene: isolation of a 1.2-Mb YAC contig spanning the entire gene and identification of heterogeneous deletions in patients with Hunter syndrome.
Palmieri G; Capra V; Romano G; D'Urso M; Johnson S; Schlessinger D; Morris P; Hopwood J; Di Natale P; Gatti R; Ballabio A
Genomics; 1992 Jan; 12(1):52-7. PubMed ID: 1733863
[TBL] [Abstract][Full Text] [Related]
24. Molecular analysis in patients with mucopolysaccharidosis type II suggests that DXS466 maps within the Hunter gene.
Steglich C; Bunge S; Hulsebos T; Beck M; Brandt NJ; Schwinger E; Hopwood JJ; Gal A
Hum Genet; 1993 Sep; 92(2):179-82. PubMed ID: 8103756
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneity of DNA and RNA in Hunter patients.
Annella T; Daniele A; Di Natale P
Hum Genet; 1993 Oct; 92(4):350-2. PubMed ID: 7693576
[TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of patients with Hunter syndrome: implication of a region prone to structural alterations within the IDS gene.
Steén-Bondeson ML; Dahl N; Tönnesen T; Kleijer WJ; Seidlitz G; Gustavson KH; Wilson PJ; Morris CP; Hopwood JJ; Pettersson U
Hum Mol Genet; 1992 Jun; 1(3):195-8. PubMed ID: 1303177
[TBL] [Abstract][Full Text] [Related]
27. Hunter disease in the Spanish population: molecular analysis in 31 families.
Gort L; Chabás A; Coll MJ
J Inherit Metab Dis; 1998 Aug; 21(6):655-61. PubMed ID: 9762601
[TBL] [Abstract][Full Text] [Related]
28. Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene.
Hopwood JJ; Bunge S; Morris CP; Wilson PJ; Steglich C; Beck M; Schwinger E; Gal A
Hum Mutat; 1993; 2(6):435-42. PubMed ID: 8111411
[TBL] [Abstract][Full Text] [Related]
29. Mucopolysaccharidosis type II: an update on mutation spectrum.
Froissart R; Da Silva IM; Maire I
Acta Paediatr; 2007 Apr; 96(455):71-7. PubMed ID: 17391447
[TBL] [Abstract][Full Text] [Related]
30. Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report.
Muenzer J; Lamsa JC; Garcia A; Dacosta J; Garcia J; Treco DA
Acta Paediatr Suppl; 2002; 91(439):98-9. PubMed ID: 12572850
[TBL] [Abstract][Full Text] [Related]
31. Genetics and Gene Therapy in Hunter Disease.
Sestito S; Falvo F; Scozzafava C; Apa R; Pensabene L; Bonapace G; Moricca MT; Concolino D
Curr Gene Ther; 2018; 18(2):90-95. PubMed ID: 29618310
[TBL] [Abstract][Full Text] [Related]
32. Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment.
D'Avanzo F; Rigon L; Zanetti A; Tomanin R
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070051
[TBL] [Abstract][Full Text] [Related]
33. Loss of Function of Mutant IDS Due to Endoplasmic Reticulum-Associated Degradation: New Therapeutic Opportunities for Mucopolysaccharidosis Type II.
Matsuhisa K; Imaizumi K
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830113
[TBL] [Abstract][Full Text] [Related]
34. Comparative studies of vertebrate iduronate 2-sulfatase (IDS) genes and proteins: evolution of A mammalian X-linked gene.
Holmes RS
3 Biotech; 2017 May; 7(1):22. PubMed ID: 28401457
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
